Alexis Borisy is a leading life sciences entrepreneur and investor, focusing over the past 25 years on building, operating, and investing in breakthrough life science-based companies.  He currently serves as the Founder, Chairman, and Chief Executive Officer of EQRx, and has been the founder, chairman, CEO, or founding investor of eight NASDAQ listed companies.  Alexis was also previously a partner at Third Rock Ventures, where he played key roles in launching and building many of Third Rock’s portfolio companies.  He currently serves as Chairman of Relay Therapeutics (RLAY) and as a Director at Blueprint Medicines (BPMC), both companies he co-founded and served a turn as CEO; he is also lead independent director of Revolution Medicines (RVMD).  Previously he was chairman of the board, co-founder and the first chief executive officer of Foundation Medicine (acquired by Roche) and Director of Thrive Earlier Detection (acquired by Exact Sciences).  Alexis also currently serves as chairman of privately held Celsius Therapeutics and as a director of Dascena.

Prior to joining Third Rock Ventures, Alexis founded CombinatoRx in 2000, serving as its chief executive officer and bringing the company public on the NASDAQ, and as a co-founder and chairman of FORMA Therapeutics. He has transacted tens of billions in financing, business development, and M&A deals, and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard where he was a Howard Hughes Predoctoral Fellow, Alexis was honored as the Massachusetts Institute of Technology’s Technology Review Innovator of the Year. He was also chosen as the New England Entrepreneur of the Year in Life Sciences and was honored as a Presidential Scholar.

Alexis’ undergraduate degree in chemistry is from the University of Chicago, and he did his graduate work in the laboratory of Dr. Stuart Schreiber at Harvard University.  Alexis previously was Chair of the National Venture Capital Association, served on the Board of the Biotechnology Industry Organization, and is currently Chair of the Board of Trustees of the Boston Museum of Science.